References
- The ALSUntangled Group. ALSUntangled Update 1: investigating a bug (Lyme disease) and a drug (Iplex). Amyotroph Lateral Scler. 2009;10:248–50.
- http://www.als-cure.com/
- http://www.owndoc.com/about/
- Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:11: 994–1003.
- Halperin J. Nervous system Lyme disease. Infect Dis Clin N Am. 2008;22:261–74.
- Murray T, Shapiro E. Lyme disease. Clin Lab Medicine. 2010;30:311–28.
- Hemmer B, Glocker F, Kaiser R, Lucking C, Deuschl G. Generalized motor neuron disease as an unusual manifestation of Borrelia burgdorferi infection. JNNP. 1997; 63:257.
- Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph Lateral Scler. 2012;13:25–32.
- http://www.euro.who.int/_data/assets/pdf_file/0006/96819/E89522.pdf
- Cronin S, Hardiman O, Traynor B. Ethnic variation in the incidence of ALS. Neurology. 2007;68:1002–7.
- http://cdc.gov/lyme/stats/chartstables/reportedcases_statelocality.html
- Lee S. Guam dementia syndrome revisited in 2011. Curr Opin Neurol. 2011;24:517–24.
- http://www.cdc.gov/mmwr/preview/mmwrhtml/ss4903al.htm
- Halerin J. Nervous system Lyme disease: is there a controversy?Seminars in Neurology. 2011;31:317–24.
- http://www.cdc.gov/lyme/diagnosistreatment/LabTest/TwoStep/
- Klempner MS, Schmidt CH, Hu L, Steere A, Johnson G, McCloud B, . Interlaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001;110: 217–9.
- Mandell H, Steere A, Reinhardt B, Yoshinari N, Munsat T. Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis. N Engl J Med. 1989;320: 255–6.
- http://www.lymenet.de/indexordner/ials.htm
- Quereshi M, Bedlack R, Cudkowicz M. Lyme disease serology in amyotrophic lateral sclerosis. Musce Nerve. 2009; 40:626–8.
- Halperin J, Kaplan G, Brazinsky S, Tsai T, Ironside A, Wu P, . Immunologic reactivity against Borrelia burdgorferi in patients with motor neuron disease. Arch Neurol. 1990;47:586–94.
- Caroscio JT, Mulvihill MN, Sterling R, Abrams B. Amyotrophic lateral sclerosis: its natural history. Neurol Clin. 1987;5:1–2212;8.
- Fredrikson S, Link H. CNS borreliosis selectively affecting central motor neurons. Acta Neurol Scand. 1988;78: 181–4.
- Harvey WT, Martz D. Motor neuron disease recovery associated with IV ceftriaxone and anti-babesia therapy. Acta Neurol Scand. 2007;115:129–31.
- http://www.creektrailmedicalclinic.com/html/history.html
- Miyoshi K, Ohyagi Y, Amano T, Inoue I, Miyoshi S, Tsuii S, . A patient with motor neuron syndrome clinically similar to amyotrophic lateral sclerosis, presenting a spontaneous recovery. Rinsho Sinkeigaku. 2000;40:1090–5.
- Tsai CP, Ho HH, Yen DJ, Wang V, Lin KP, Liao KK, Wu Z. Reversible motor neuron disease. Eur Neurol. 1993;33: 387–9.
- Tucker T, Layzer R, Miller R, Chad D. Subacute, reversible motor neuron disease. Neurology. 1991;41:1541–4.
- Tucker T. Subacute, reversible motor neuron disease. Taehan Singyongkwa Hakhoe chi. 1991;41:1541.
- Halperin J, Shapiro E, Logigian E, Belman L, Dotevall L, Wormser G, . Practice parameter: treatment of nervous system Lyme disease (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69:91–102.
- Wormser G, Dattwyler R, Shapiro E, Halperin J, Steere A, Klempner M, . The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–1134.
- Lantos P, Charini W, Medoff G, Moro M, Mushatt D, Parsonnet J, . Final report of the Lyme disease review panel of the Infectious Diseases Society of America. CID. 2010;51:1–5.
- Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, . Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurol. 2007;6:1045–53.
- Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH, Johnson H, Qureshi M, . A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003;61:456–64.
- Miller RG, Moore DH, Forshew DA, Katz JS, Barohn RJ, Valan M, . Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology. 2011;77:973–9.
- Gordon PH, Moore DH, Gelinas DF, Qualls C, Mester ME, Werner J, . Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology. 2004;62:1845–7.
- Griffin G. New insights into the pathophysiology of the Jarisch-Herxheimer reaction. Antimicrob Chemother. 1992; 29:613–6.
- http://www.va.gov/opa/pressrel/pressrelease.cfm?id = 1583
- http://www.dukehealth.org/physicians/richard_s_bedlack
- http://www.whois.net/whois/alsuntangled.com